CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea · Delayed Price · Currency is KRW 1,783.00
+78.00 (4.57%)
At close: Jul 31, 2026
CU Medical Systems Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 54,664 | 48,223 | 40,629 | 41,803 | 46,957 | 35,402 |
Revenue Growth | 42.23% | 18.69% | -2.81% | -10.98% | 32.64% | 25.01% |
Gross Profit Gross Profit Growth | 31,383 | 28,438 | 21,460 | 20,324 | 24,648 | 18,422 |
Operating Income Operating Income Growth | 12,454 | 11,073 | 7,354 | 5,060 | 11,282 | 2,376 |
Net Income Net Income Growth | 3,185 | 819.2 | -3,204 | -8,204 | 9,425 | -13,981 |
Earnings Per Share EPS Growth | 64.09 | 67.68 | -315.00 | -860.00 | 1043.92 | -2060.53 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 9,156 | 8,220 | 8,714 | 10,709 | 8,894 | 6,979 |
Asia Asia Growth | 10,711 | 10,341 | 9,583 | 8,693 | 7,379 | 6,694 |
Europe Europe Growth | 30,783 | 27,186 | 19,627 | 19,357 | 27,346 | 18,784 |
Middle East Middle East Growth | 800.87 | 638.95 | 758.59 | 563.09 | 701.6 | 429.46 |
Africa Africa Growth | 321.02 | 79.58 | 82.19 | 113.09 | 134.79 | 118.78 |
Americas Americas Growth | 1,952 | 900.55 | 1,080 | 1,599 | 1,388 | 1,292 |
Oceania Oceania Growth | 939.45 | 856.87 | 784.41 | 768.94 | 1,114 | 1,105 |
Total Total Growth | 54,664 | 48,223 | 40,629 | 41,803 | 46,957 | 35,402 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 24,626 | 25,372 | 22,270 | 9,872 | 7,035 | 11,845 |
Total Debt Total Debt Growth | 46,943 | 33,395 | 37,390 | 23,700 | 19,751 | 14,909 |
Net Cash (Debt) Net Cash Growth | -22,317 | -8,022 | -15,120 | -13,828 | -12,716 | -3,064 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1748.77 | -662.74 | -1486.31 | -1446.14 | -1408.40 | -451.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13,356 | 9,687 | 14,072 | 8,275 | 3,121 | 490.43 |
Capital Expenditures CapEx Growth | -1,049 | -1,058 | -20,056 | -6,382 | -11,586 | -5,186 |
Free Cash Flow Free Cash Flow Growth | 12,308 | 8,629 | -5,984 | 1,893 | -8,465 | -4,696 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.41% | 58.97% | 52.82% | 48.62% | 52.49% | 52.04% |
Operating Margin | 22.78% | 22.96% | 18.10% | 12.11% | 24.03% | 6.71% |
Pretax Margin | 6.79% | 3.13% | -6.09% | -17.81% | 22.25% | -42.77% |
Profit Margin | 5.83% | 1.70% | -7.89% | -19.63% | 20.07% | -39.49% |
FCF Margin | 22.52% | 17.89% | -14.73% | 4.53% | -18.03% | -13.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.82 | 40.64 | - | - | 6.32 | - |
P/FCF Ratio | 1.75 | 3.86 | - | 21.69 | - | - |
PS Ratio | 0.39 | 0.69 | 1.00 | 0.98 | 1.27 | 1.46 |